Cargando…
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study
BACKGROUND: Paclitaxel is widely used for the treatment of metastatic breast cancer (MBC). However, it has a low oral bioavailability due to gut extrusion caused by P-glycoprotein (P-gp). Oral paclitaxel (oPAC) may be more convenient, less resource-intensive, and more tolerable than its intravenous...
Autores principales: | Dai, Ming-Shen, Chao, Ta-Chung, Chiu, Chang-Fang, Lu, Yen-Shen, Shiah, Her-Shyong, Jackson, Christopher G. C. A., Hung, Noelyn, Zhi, Jianguo, Cutler, David L., Kwan, Rudolf, Kramer, Douglas, Chan, Wing-Kai, Qin, Albert, Tseng, Kuan-Chiao, Hung, Cheung Tak, Chao, Tsu-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363869/ https://www.ncbi.nlm.nih.gov/pubmed/37492633 http://dx.doi.org/10.1177/17588359231183680 |
Ejemplares similares
-
Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
por: Rugo, Hope S., et al.
Publicado: (2023) -
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors
por: He, Jimmy, et al.
Publicado: (2022) -
Breast milk paclitaxel excretion following intravenous chemotherapy—a case report
por: Jackson, Christopher G. C. A., et al.
Publicado: (2019) -
Chemopreventive effects of Xiang Sha Liu Jun Zi Tang on paclitaxel-induced leucopenia and neuropathy in animals
por: Shiah, Her-Shyong, et al.
Publicado: (2023) -
Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients
por: Menkes, David B., et al.
Publicado: (2017)